193 related articles for article (PubMed ID: 15209536)
1. What may be the markers of the male equivalent of polycystic ovary syndrome?
Dusková M; Cermáková I; Hill M; Vanková M; Sámalíková P; Stárka L
Physiol Res; 2004; 53(3):287-94. PubMed ID: 15209536
[TBL] [Abstract][Full Text] [Related]
2. Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome?
Starka L; Duskova M; Cermakova I; Vrbiková J; Hill M
Endocr Regul; 2005 Dec; 39(4):127-31. PubMed ID: 16552990
[TBL] [Abstract][Full Text] [Related]
3. [The polycystic ovary syndrome and its male equivalent].
Dusková M; Hill M; Stráka L
Cas Lek Cesk; 2007; 146(3):251-5. PubMed ID: 17419309
[TBL] [Abstract][Full Text] [Related]
4. The existence of a male equivalent of the polycystic ovary syndrome--the present state of the issue.
Dusková M; Stárka L
Prague Med Rep; 2006; 107(1):17-25. PubMed ID: 16752800
[TBL] [Abstract][Full Text] [Related]
5. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
[TBL] [Abstract][Full Text] [Related]
7. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
8. [Hormonal profile in men with premature androgenic alopecia].
Stárka L; Hill M; Polácek V
Sb Lek; 2000; 101(1):17-22. PubMed ID: 10953626
[TBL] [Abstract][Full Text] [Related]
9. Insulin gene polymorphism in women with polycystic ovary syndrome.
Ferk P; Perme MP; Gersak K
J Int Med Res; 2008; 36(6):1180-7. PubMed ID: 19094425
[TBL] [Abstract][Full Text] [Related]
10. Male PCOS equivalent and nutritional restriction: Are we stepping forward?
Di Guardo F; Cerana MC; D'urso G; Genovese F; Palumbo M
Med Hypotheses; 2019 May; 126():1-3. PubMed ID: 31010486
[TBL] [Abstract][Full Text] [Related]
11. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
12. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
[TBL] [Abstract][Full Text] [Related]
13. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome.
Vanková M; Vrbíková J; Hill M; Cinek O; Bendlová B
Ann N Y Acad Sci; 2002 Jun; 967():558-65. PubMed ID: 12079889
[TBL] [Abstract][Full Text] [Related]
14. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
15. Hormonal profile of men with premature balding.
Stárka L; Cermáková I; Dusková M; Hill M; Dolezal M; Polácek V
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):24-8. PubMed ID: 14758568
[TBL] [Abstract][Full Text] [Related]
16. No association of the insulin gene VNTR polymorphism with polycystic ovary syndrome in a Han Chinese population.
Xu Y; Wei Z; Zhang Z; Xing Q; Hu P; Zhang X; Gao G; Wang Y; Gao Q; Yi L; Cao Y
Reprod Biol Endocrinol; 2009 Dec; 7():141. PubMed ID: 19948072
[TBL] [Abstract][Full Text] [Related]
17. Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure.
Greenwood EA; Noel MW; Kao CN; Shinkai K; Pasch LA; Cedars MI; Huddleston HG
Fertil Steril; 2016 Feb; 105(2):486-93. PubMed ID: 26551442
[TBL] [Abstract][Full Text] [Related]
18. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.
Waterworth DM; Bennett ST; Gharani N; McCarthy MI; Hague S; Batty S; Conway GS; White D; Todd JA; Franks S; Williamson R
Lancet; 1997 Apr; 349(9057):986-90. PubMed ID: 9100625
[TBL] [Abstract][Full Text] [Related]
19. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
[TBL] [Abstract][Full Text] [Related]
20. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
